tradingkey.logo
搜索

Taysha Gene Therapies Inc

TSHA
添加自选
5.860USD
-0.015-0.26%
收盘 07-31 16:00美东报价延迟15分钟
1.87B总市值
亏损市盈率 TTM

TSHA 财务数据

通过专为投资者打造的一站式数据看板,全面查看 Taysha Gene Therapies Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。

Taysha Gene Therapies Inc财报日历

最新发布
5月 6, 2026
每股收益 / 预测值
-0.12/-0.10
营业收入 / 预测值
0.00/680.00K
报告期
FY2025 财报
营业收入(YoY)
9.77M
17.28%
每股收益(YoY)
-0.34
4.50%
分析师评级
BUY
2026/08/02
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
财务指标
每股收益
-44.70%-0.12
-11.36%-0.08
2.78%-0.09
-0.36%-0.09
23.17%-0.08
-130.87%-0.07
89.77%-0.10
76.52%-0.09
62.65%-0.10
123.00%0.23
---0.93
---0.38
---0.28
---0.99
---2.79
----
----
----
----
----
营业收入
-100.00%0.00
171.27%5.49M
-100.00%0.00
78.60%1.99M
-32.51%2.30M
-43.90%2.02M
-62.33%1.79M
-53.57%1.11M
-27.52%3.41M
44.04%3.60M
--4.75M
--2.40M
--4.71M
--2.50M
--0.00
--0.00
--0.00
----
----
----
净利润
-96.99%-42.41M
-48.26%-27.85M
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
185.68%47.74M
-341.39%-117.09M
27.85%-24.60M
64.98%-17.62M
-10.59%-55.72M
48.18%-26.53M
16.70%-34.09M
-57.12%-50.32M
-175.06%-50.39M
-240.29%-51.19M
---40.93M
利润率
----
45.34%-507.77%
----
28.08%-1353.58%
-32.58%-935.23%
-170.13%-929.03%
42.14%-1427.52%
-83.24%-1882.01%
-88.38%-705.39%
159.48%1324.67%
---2467.07%
---1027.06%
---374.46%
---2227.14%
----
----
----
----
----
----
毛利率
----
0.00%100.00%
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
资产负债率
-47.07%16.39%
-46.81%14.70%
-32.59%16.22%
-34.49%12.49%
15.94%30.97%
16.86%27.65%
21.08%24.06%
-59.82%19.07%
-29.48%26.72%
-21.32%23.66%
--19.87%
--47.45%
--37.88%
--30.07%
--33.89%
----
----
----
----
----
营业收入
-100.00%0.00
171.27%5.49M
-100.00%0.00
78.60%1.99M
-32.51%2.30M
-43.90%2.02M
-62.33%1.79M
-53.57%1.11M
-27.52%3.41M
44.04%3.60M
--4.75M
--2.40M
--4.71M
--2.50M
--0.00
--0.00
--0.00
----
----
----
营业利润
-103.01%-43.49M
-41.98%-28.30M
-61.56%-34.02M
-25.61%-26.75M
11.96%-21.42M
-26.18%-19.93M
-34.71%-21.06M
8.92%-21.30M
-46.93%-24.33M
15.52%-15.80M
38.59%-15.63M
29.93%-23.38M
66.65%-16.56M
62.39%-18.70M
49.77%-25.46M
18.15%-33.37M
-54.72%-49.65M
-170.72%-49.72M
-236.95%-50.68M
---40.77M
净利润
-96.99%-42.41M
-48.26%-27.85M
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
185.68%47.74M
-341.39%-117.09M
27.85%-24.60M
64.98%-17.62M
-10.59%-55.72M
48.18%-26.53M
16.70%-34.09M
-57.12%-50.32M
-175.06%-50.39M
-240.29%-51.19M
---40.93M
流动资产
133.83%282.25M
128.42%324.65M
85.66%299.95M
77.21%316.26M
-7.57%120.71M
-5.16%142.13M
-5.97%161.56M
229.80%178.47M
80.49%130.60M
55.44%149.87M
299.53%171.81M
-29.57%54.12M
-32.31%72.36M
-39.59%96.42M
-78.19%43.00M
-62.94%76.83M
-55.39%106.89M
-38.11%159.60M
-29.39%197.17M
1734.69%207.30M
流动负债总额
-10.90%20.10M
1.24%26.55M
-2.40%28.63M
-25.83%25.35M
-41.62%22.56M
-28.65%26.23M
-83.74%29.34M
-32.51%34.18M
-29.05%38.64M
-41.46%36.76M
444.53%180.45M
17.90%50.64M
12.01%54.45M
21.34%62.79M
-23.31%33.14M
51.29%42.95M
156.45%48.62M
625.85%51.75M
271.77%43.21M
41.32%28.39M
总资产
117.08%300.35M
114.09%343.32M
75.65%316.55M
66.34%333.33M
-9.57%138.36M
-7.16%160.36M
-7.94%180.22M
145.75%200.39M
50.59%153.00M
36.79%172.73M
75.63%195.77M
-42.71%81.54M
-38.79%101.60M
-40.98%126.28M
-53.76%111.47M
-41.15%142.33M
-31.65%165.98M
-17.35%213.96M
-13.69%241.04M
2036.95%241.86M
总负债
6.13%88.41M
8.49%96.38M
6.72%97.56M
-7.56%84.60M
-15.98%83.30M
-9.16%88.84M
-62.67%91.42M
-22.87%91.53M
-14.93%99.15M
-21.97%97.79M
144.05%244.88M
8.24%118.66M
1.13%116.55M
5.70%125.33M
-0.30%100.34M
98.00%109.62M
477.50%115.25M
1464.49%118.57M
765.86%100.65M
175.58%55.37M
总权益
284.94%211.94M
245.25%246.94M
146.62%218.99M
128.47%248.73M
2.25%55.06M
-4.55%71.53M
280.80%88.80M
393.33%108.87M
460.24%53.85M
7796.42%74.94M
-541.43%-49.11M
-213.46%-37.11M
-129.47%-14.95M
-99.01%949.00K
-92.08%11.13M
-82.46%32.71M
-77.24%50.73M
-62.04%95.38M
-47.54%140.39M
2225.94%186.50M
经营净额
-85.64%-40.88M
-45.96%-26.72M
-11.80%-24.17M
6.15%-20.18M
-11.22%-22.02M
-13.59%-18.31M
-20.42%-21.61M
-14.58%-21.50M
1.92%-19.80M
-212.89%-16.12M
37.70%-17.95M
43.73%-18.77M
50.69%-20.18M
135.46%14.28M
9.78%-28.81M
-46.18%-33.35M
-85.79%-40.94M
-102.83%-40.26M
-375.48%-31.93M
---22.82M
投资净额
-715.09%-3.02M
-2000.00%-247.00K
-37.14%-48.00K
130.85%62.00K
-165.00%-371.00K
230.00%13.00K
99.00%-35.00K
-518.75%-201.00K
96.41%-140.00K
99.58%-10.00K
-15.56%-3.49M
100.59%48.00K
65.87%-3.90M
72.18%-2.37M
24.54%-3.02M
4.53%-8.11M
-2039.89%-11.43M
-40.80%-8.52M
-12809.68%-4.00M
---8.50M
融资净额
1467.31%711.00K
13981.23%49.56M
33.39%8.80M
206.93%216.29M
-136.36%-52.00K
91.60%-357.00K
-95.31%6.59M
18591.78%70.47M
94.05%-22.00K
-110.20%-4.25M
136637.86%140.63M
-96.60%377.00K
-245.79%-370.00K
357.63%41.67M
-100.34%-103.00K
--11.07M
---107.00K
714.37%9.11M
-89.07%29.98M
--0.00

常见问题

Taysha Gene Therapies Inc的总收入是多少?

根据Taysha Gene Therapies Inc的FY2025财报,总收入达到了9.77M(同比变化8.33M)。

Taysha Gene Therapies Inc的流动资产是多少?

根据Taysha Gene Therapies Inc的FY2025财报,流动资产为324.65M(同比变化128.42)。

Taysha Gene Therapies Inc的总资产是多少?

根据Taysha Gene Therapies Inc的FY2025财报,Taysha Gene Therapies Inc的总资产为343.32M(同比变化114.09)。

Taysha Gene Therapies Inc的总负债是多少?

根据Taysha Gene Therapies Inc的FY2025财报,Taysha Gene Therapies Inc的总负债为96.38M(同比变化8.49)。

Taysha Gene Therapies Inc的总权益是多少?

根据Taysha Gene Therapies Inc的FY2025财报,Taysha Gene Therapies Inc的总权益为246.94M(同比变化245.25)。

Taysha Gene Therapies Inc的净营业收入是多少?

根据Taysha Gene Therapies Inc的FY2025财报,Taysha Gene Therapies Inc的净营业收入为-110.50M(同比变化-27.56)。

Taysha Gene Therapies Inc的净投资是多少?

根据Taysha Gene Therapies Inc的FY2025财报,Taysha Gene Therapies Inc的净投资为-604.00K(同比变化-66.39)。

Taysha Gene Therapies Inc的净融资是多少?

根据Taysha Gene Therapies Inc的FY2025财报,Taysha Gene Therapies Inc的净融资为274.59M(同比变化258.08)。

Taysha Gene Therapies Inc的每股收益(EPS)是多少?

根据Taysha Gene Therapies Inc的FY2025财报,每股收益(EPS)为-0.34(同比变化4.50)。

Taysha Gene Therapies Inc的净利润是多少?

根据Taysha Gene Therapies Inc的FY2025财报,净利润为-109.00M(同比变化-22.06)。

Taysha Gene Therapies Inc的净利润率是多少?

根据Taysha Gene Therapies Inc的FY2025财报,净利润率为-1115.27(同比变化-4.07)。

Taysha Gene Therapies Inc的债务与资产比率是多少?

根据Taysha Gene Therapies Inc的FY2025财报,债务与资产比率为14.70(同比变化-47.26)。

Taysha Gene Therapies Inc的股东权益回报率(ROE)是多少?

根据Taysha Gene Therapies Inc的FY2025财报,股东权益回报率(ROE)为-68.45(同比变化43.87)。

Taysha Gene Therapies Inc的资产回报率(ROA)是多少?

根据Taysha Gene Therapies Inc的FY2025财报,资产回报率(ROA)为-43.28(同比变化19.28)。

Taysha Gene Therapies Inc的营业利润是多少?

根据Taysha Gene Therapies Inc的FY2025财报,营业利润为-110.50M(同比变化-27.56)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有